Hyperbaric on Pulmonary Functions in Post Covid -19 Patients.
Post COVID-19 Patients
About this trial
This is an interventional treatment trial for Post COVID-19 Patients
Eligibility Criteria
Inclusion Criteria 1. post Covid -19 patients (2weeks after recovery). 2.post Covid -19 patients with deficiency in forced vital capacity (less than 80%) forced expiratory volume (less than 80%) lower oxygen saturation (90%-95%). 3.age (21-66)years old. 4.both gender. 5.BMI 25.0-29.9. Exclusion Criteria: COPD or other respiratory diseases. Neurological disease. mental illness. Critically ill patients with intubation. smokers. Inner ear diseases. pregnancy.
Sites / Locations
- Faculty of Physical Therapy
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
hyperbaric oxygen therapy ,breathing exercise,medical treatment
breathing exercise and medical treatment
Hyperbaric oxygen treatment HBO treatment was given daily in the morning on 21 consecutive days. (HBOT) treatment is a procedure performed inside a pressured chamber (the Hyperbaric Chamber). The patient is place inside the chamber exposure to 100% oxygen at 2 ATA with 5 min air breaks every 20 min. Each session consisted of 60 min. Measurements will be taken in the morning before entering, the first and last session.
breathing exercise completely each session of three repetitions initially. Every repetition consisted of one round of intervention 10-15 times followed by a brief rest (normal breathing) of <1 min (one repetition). Such 3 repetitions were given initially & advanced till 10 repetitions (one session) by last day of the week. In this manner participants practised 3 sessions twice a day, for a total duration of about 10-20 min every day.Vitamin D: The recommended dietary dose of vitamin D is 600 IU each day . Vitamine C: The recommended dietary dose 200 mg/day vitamin C. Anticoagulation drugs (blood thinners), doctors usually prescribe low-molecular-weight heparin (enoxaparin) (30 mg), each given subcutaneously every 12 hours